Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in glycine antagonists.

M Antolini1, D Donati, F Micheli

  • 1Glaxo Wellcome SpA, Medicines Research Center, Via Fleming 4, 37100 Verona, Italy. fm20244@glaxowellcome.co.uk

Current Opinion in Investigational Drugs (London, England : 2000)
|March 16, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retrospective analysis of ultrasound-guided hydrodistension in patients with post-traumatic adhesive capsulitis of the shoulder.

Musculoskeletal surgery·2025
Same author

A narrative review on greater trochanteric pain syndrome: diagnostic imaging and non-surgical treatments.

Musculoskeletal surgery·2025
Same author

Unveiling complexity: A detailed case report on type 1 diabetes and its rare camptodactyly complication.

Morphologie : bulletin de l'Association des anatomistes·2024
Same author

Exploring the impact of rehabilitation on post-surgical recovery in elbow fracture patients: a cohort study.

Musculoskeletal surgery·2024
Same author

The mechanics of the collateral ligaments in the metacarpophalangeal joints: A scoping review.

Morphologie : bulletin de l'Association des anatomistes·2024
Same author

Corrigendum to "SELNET clinical practice guidelines for soft tissue sarcoma and GIST" [Cancer Treat. Rev. 102 (2021) 102312].

Cancer treatment reviews·2023
Same journal

Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?

Current opinion in investigational drugs (London, England : 2000)·2011
Same journal

Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.

Current opinion in investigational drugs (London, England : 2000)·2010
See all related articles

This review summarizes recent advancements in glycine antagonists, focusing on their therapeutic potential. Several promising molecules are nearing completion of clinical trials for various medical applications.

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Drug Discovery

Background:

  • Glycine antagonists represent a significant area of research in neuroscience and therapeutics.
  • Recent literature highlights diverse chemical classes of these antagonists.
  • Understanding their mechanisms is crucial for developing new treatments.

Purpose of the Study:

  • To review scientific and patent literature on glycine antagonists from the past two years.
  • To explore the therapeutic applications of various glycine antagonist classes.
  • To identify molecules in advanced clinical development.

Main Methods:

  • Comprehensive literature search of scientific databases.
  • Analysis of patent filings related to glycine antagonists.

Related Experiment Videos

  • Review of clinical trial progress for identified compounds.

    • Main Results:

    • Identification of multiple classes of glycine antagonists.
    • Detailed overview of their potential therapeutic targets.
    • Confirmation that many compounds are in late-stage clinical trials.

    Conclusions:

    • Glycine antagonists show considerable promise for therapeutic applications.
    • Ongoing clinical studies suggest near-term availability of new treatments.
    • This field continues to evolve with novel molecular designs and applications.